MEBO Group and Julphar: Celebrating 30 Years of Strategic Collaboration in Global Healthcare
On September 13, 2024, MEBO Group Chairman Kevin Xu welcomed a distinguished delegation from Julphar to MEBO's Shanghai Biotech facility. Led by His Highness Sheikh Saqr Bin Humaid Al Qassimi, CEO Basel Ziyadeh, and Chief Strategy Officer Juergen Lauterbach, the delegation was greeted by Vice Presidents Liu Gang and Shang Qingxin.
Strengthening a Three-Decade Partnership
The visit kicked off with a strategic meeting where both parties reflected on their long-standing partnership and discussed future opportunities for deepening cooperation. Topics included strengthening mutual trust, expanding diverse business collaborations, and exploring innovative opportunities. Chairman Xu warmly welcomed the delegation, recalling his first meeting with Sheikh Saqr in Ras Al Khaimah in 2019. He also highlighted MEBO Group's recent global initiatives, particularly the successes of the 2023 MEBO APEC Summit. Xu expressed his hope that APEC would serve as a platform for even broader collaboration between MEBO and Julphar, especially in the fields of entertainment, sports, and public projects, contributing to a better global future.
Touring MEBO’s Advanced Facilities
After the discussions, the Julphar delegation toured MEBO’s GMP facility and production lines, as well as the MEBO Memorial Museum in Shanghai. The visitors were impressed by MEBO's rich history, cutting-edge technology, and modern production capabilities. The delegation expressed admiration for Kevin Xu’s global vision and expressed confidence in a bright future of shared growth and innovation.
Julphar, the largest pharmaceutical company in the Middle East, is a key player in the region, benefiting from its strategic location, robust market system, and strong financial capacity. Since 1995, MEBO and Julphar have built a solid and inseparable partnership, expanding MEBO’s footprint in the Middle East, Africa, and Latin America. In 2018, the two companies collaborated on the “Every Woman, Every Child” regeneration initiative in Egypt and Lebanon, marking a new chapter in their global health efforts.
A Vision for Global Healthcare
Looking ahead to 2025, which will mark 30 years of collaboration between MEBO and Julphar, both parties are optimistic about the future. This meeting signals the start of new opportunities and innovative partnerships that will continue to strengthen their cooperation. Together, MEBO and Julphar are set to shape the future of global healthcare, providing a model for international collaboration.
About MEBO
Founded in 1987 by Professor Rongxiang Xu, a distinguished Chinese life scientist, MEBO Group is a multinational headquartered in both China and the USA. It integrates research, development, and sales across the pharmaceuticals, medical devices, health foods, and cosmetics sectors.
At its core, MEBO focuses on regenerative life sciences, innovating with over 100 patents and more than ten joint research bases to enhance and enable the body's own regenerative abilities.
As a leader in regenerative life science, MEBO's extensive research facilities and products impact over 100 countries globally, pioneering new frontiers in the regenerative life world.
About Julphar
The United Arab Emirates (UAE), officially known as the United Arab Emirates, is composed of seven emirates, with Abu Dhabi as the capital, Dubai as the economic hub, and Ras Al Khaimah, the fourth-largest emirate, serving as the country’s industrial center. Among its key industries, Gulf Pharmaceutical Industries (Julphar) is the largest pharmaceutical manufacturer in the Middle East. Sheikh Saud Bin Saqr Al Qasimi is the son of the former ruler of Ras Al Khaimah, Sheikh Saqr Bin Mohammad Al Qasimi. After Sheikh Saqr's passing in October 2010, Sheikh Saud succeeded him as ruler and swiftly implemented a series of economic policies to advance Ras Al Khaimah, including the establishment of the RAK Governmental Investment Authority.
In 1980, Sheikh Saqr Bin Mohammad Al Qasimi founded Gulf Pharmaceutical Industries (Julphar) and in the early 1990s, he met Professor Rongxiang Xu, introducing Moist Exposed Burn Therapy (MEBT) and its products to the region. Sheikh Saud Bin Saqr Al Qasimi and his brother, Sheikh Faisal Bin Saqr Al Qasimi, consecutively served as chairmen of Julphar, fostering a close, friendly relationship with the MEBO Group board for over 30 years. Their strategic cooperation has rapidly expanded into international markets across the Middle East, Africa, and Latin America. The current Julphar chairman, Sheikh Saqer Bin Humaid Al Qasimi, is also a member of the Al Qasimi royal family.
stay informed. connect with us.
